Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia.
Blood Cancer J
; 11(11): 182, 2021 11 16.
Article
in En
| MEDLINE
| ID: mdl-34785653
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Receptors, Antigen, T-Cell, gamma-delta
/
Protein Kinase Inhibitors
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2021
Document type:
Article